Dr. Kelli Gills, a May 16th graduate from Morehouse School of Medicine in Atlanta will head a free COVID-19 screening antibody testing June 12-13, at 6330 S. King Drive, from 12:00 – 3:00 p.m. She will be joined by other medical practitioners in the screening efforts. The antibody initiative is co-partnered with Project H.O.O.D.

“During the course of two days, we will be conducting a COVID-19 screening for antibodies 1gG and 1gM to determine whether participants have an active infection or whether they’ve already had the coronavirus. We are only offering 200 tests, so our goal is to screen 100 participants each day over a two-day period,” Dr. Gills said.

Dr. Gills emphasized that testing is on a first come first serve basis. She also added that testing will be for one person per household. The antibody initiative will serve as a pilot to determine whether the testing will be needed for ongoing efforts. She encourages the medical community to also volunteer their much-needed services and expertise.

“Knowing how many people were actually exposed and developed antibodies will help officials understand how dangerous it truly is,” said Michael Mina, MD, Ph.D., an assistant professor of epidemiology at the Harvard T.H. Chan School of Public Health. “While millions of people worldwide have been diagnosed with COVID-19, many more have probably had it and were unable to get tested or didn’t even notice the infection,” he pointed out.

In addition, Mina added that one thing antibody tests answers is “Was I infected?” Mina discussed the antibody initiative in a Webmd interview on April 16th. https://www.webmd.com/lung/news/20200416/what-can-antibody-testing-really-tell-us-about-covid

Dr. Kelli Gills is a native Chicagoan. She is a 2011 graduate of Whitney Young Magnet High School. In 2015, she received a B.S. in Biology from Jackson State University, and in 2020, Dr. Gills received an M.S. in Medical Science from Morehouse College. Her field of expertise is in General Surgery. The antibody screening event was sponsored by black-owned medical companies.